Drug Type Small molecule drug |
Synonyms GLIX1 + PARPi |
Target |
Action inhibitors, agonists |
Mechanism PARP inhibitors(Poly (ADP-Ribose) polymerase inhibitors), TET2 agonists(tet methylcytosine dioxygenase 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Norway | - |





